# Self-Injury: Diagnosis and Treatment

> **NCT00065936** · PHASE3 · UNKNOWN · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 37 (—)

## Conditions studied

- Self-Injurious Behavior
- Mental Retardation

## Interventions

- **DRUG:** Naltrexone hydrochloride
- **PROCEDURE:** Transcutaneous sensory nerve stimulation

## Key facts

- **NCT ID:** NCT00065936
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** 2002-06
- **Target enrollment:** 37 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065936, "Self-Injury: Diagnosis and Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00065936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*